New Delhi: Drug major Sun Pharmaceutical Industries on Tuesday said its board has approved Rs 1,700 crore share buyback offer at a maximum price of Rs 425 per share.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/2Qmjyje
via IFTTT
Subscribe to:
Post Comments (Atom)
-
How to get mentally prepared during the outbreak of COVID-19? (1) Adjust your attitudes and view COVID-19 from a scientific perspective....
-
The health ministry has asked AIIMS to designate part of the new emergency wing at its trauma facility, Jai Prakash Narayan Apex Trauma Cent...
-
By Reuters via NYT World https://ift.tt/2vrReVu
No comments:
Post a Comment